Literature DB >> 11204825

In vitro model of atherosclerosis using coculture of arterial wall cells and macrophage.

Y Wada1, A Sugiyama, T Kohro, M Kobayashi, M Takeya, M Naito, T Kodama.   

Abstract

In order to determine the precise mechanism of the interactions between different types of cells, which are common phenomena in tissues and organs, the importance of coculture techniques are becoming increasingly important. In the area of cardiology, artificial arteries have been developed, based on the understanding of physiological communication of the arterial smooth muscle cells (SMC), endothelial cells (EC), and the extracellular matrix (ECM). In the study of atherosclerosis, the modification of low-density lipoprotein (LDL), which result in the recruitment and accumulation of white blood cells, especially, monocytes/macrophages, and foam cell formation, are hypothesized. Although there are well known animal models, an in vitro model of atherogenesis with a precisely known atherogenesis mechanism has not yet been developed. In this paper, an arterial wall reconstruction model using rabbit primary cultivated aortic SMCs and ECs, was shown. In addition, human peripheral monocytes were used and the transmigration of monocytes was observed by scanning electron and laser confocal microscopy. Monocyte differentiation into macrophages was shown by immunohistochemistry and comprehensive gene expression analysis. With the modified form of LDL, the macrophages were observed to accumulate lipids with a foamy appearance and differentiate into the foam cells in the ECM between the ECs and SMCs in the area of our coculture model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204825     DOI: 10.3349/ymj.2000.41.6.740

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  8 in total

1.  Smooth muscle cells orchestrate the endothelial cell response to flow and injury.

Authors:  Mercedes Balcells; Jordi Martorell; Carla Olivé; Marina Santacana; Vipul Chitalia; Angelo A Cardoso; Elazer R Edelman
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.

Authors:  George A Truskey
Journal:  Int J High Throughput Screen       Date:  2010-10-01

3.  A system for the direct co-culture of endothelium on smooth muscle cells.

Authors:  Mark D Lavender; Zhengyu Pang; Charles S Wallace; Laura E Niklason; George A Truskey
Journal:  Biomaterials       Date:  2005-01-13       Impact factor: 12.479

4.  Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Authors:  Somali Chaterji; Kinam Park; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

5.  Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections.

Authors:  Reshmi Rajendran; John A Ronald; Tao Ye; Ren Minqin; John W Chen; Ralph Weissleder; Brian K Rutt; Barry Halliwell; Frank Watt
Journal:  Microsc Microanal       Date:  2009-08       Impact factor: 4.127

6.  Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro.

Authors:  Erica B Peters; Nicolas Christoforou; Kam W Leong; George A Truskey
Journal:  Tissue Eng Part A       Date:  2012-11-21       Impact factor: 3.845

7.  A tunable microfluidic 3D stenosis model to study leukocyte-endothelial interactions in atherosclerosis.

Authors:  Nishanth Venugopal Menon; Hui Min Tay; Kuin Tian Pang; Rinkoo Dalan; Siew Cheng Wong; Xiaomeng Wang; King Ho Holden Li; Han Wei Hou
Journal:  APL Bioeng       Date:  2018-01-02

8.  A three-dimensional engineered artery model for in vitro atherosclerosis research.

Authors:  Jérôme Robert; Benedikt Weber; Laura Frese; Maximilian Y Emmert; Dörthe Schmidt; Arnold von Eckardstein; Lucia Rohrer; Simon P Hoerstrup
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.